MEDICO
Pharmaceuticals & Drugs
₹78.6
0.00 (0.00%)
Market Cap | 653 Cr | EPS | 0.9 | High | 79.35 | ||
Stock P/E | 84.1 | Net Profit Margin | 5.7 | Low | 77.4 |
Performance
Today’s Low
Today’s High
77.4
79.35
52W Low
52W High
64.55
379.95
Open Price | 77.4 | Volume | 317 |
Prev. Close | 77.9 |
Fundamentals
Market Cap | 653 Cr | ROE | 18.0% | ||
P/E Ratio(TTM) | 84.1 | EPS(TTM) | 0.0 | ||
P/B Ratio | 13.7 | Dividend Yield | 0.0% | ||
Industry P/E | 40.7 | Book Value | 5.7 | ||
Face Value | 2.0 |
About the Company
The company was incorporated as Medico Remedies Private Limited on March 18, 1994 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of Company was changed to a public limited company and the name of Company was changed to Medico Remedies Limited by a special resolution passed on January 12, 2017. A fresh Certificate of Incorporation consequent upon conversion was issued on March 06, 2017 by the Registrar of Companies, Mumbai.
They serve wholesalers or traders of formulation products. The company exports its products to Uganda, Myanmar, Vietnam, Cambodia, Dominican Republic, Sri Lanka, Philippines, Turkmenistan, Ghana, Mauritius, Madagascar, Congo, Iraq, Honduras, Cuba, Jamaica, Hong Kong, Nigeria, Senegal, Panama, Mozambique etc. The company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments. Currently, it is engaged in manufacture of formulations for various medicines. Its clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. MRL also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.
Business area of the company:
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.
Key Events and Milestones:
- 1994: Incorporated under Companies Act, 1956 as Medico Remedies Private Limited.
- 1999: Acquired plot at Palghar for setting up manufacturing set-up for general formulations.
- 2002: Acquired plot at Palghar for setting up manufacturing set-up for beta lactam.
- 2016: Renewed WHO-GMP Certification for their manufacturing facility.
- 2016: Purchased corporate premises at ‘Hubtown Solaris’.
- 2017: Renewed ISO-9001:2015 Certification for their manufacturing facility.
- 2017: Converted into a public limited company and the name of company was changed to Medico Remedies Ltd.
Parent Organization | Medico Remedies Ltd. | Managing Director | Harshit Mehta | ||
Founded | 1994 | NSE Symbol | MEDICO |
Financials
All values are in Rs Cr
Shareholding Pattern
Domestic Institutions
0.00%
Foreign Institutions
0.00%
Mutual Funds
0.00%
Promoters
73.34%
Domestic Institutions
0.00%
Foreign Institutions
0.00%
Mutual Funds
0.00%
Promoters
73.34%
Domestic Institutions
0.00%
Foreign Institutions
0.00%
Mutual Funds
0.00%
Promoters
73.34%
Domestic Institutions
0.00%
Foreign Institutions
0.00%
Mutual Funds
0.00%
Promoters
73.34%
Domestic Institutions
0.00%
Foreign Institutions
0.00%
Mutual Funds
0.00%
Promoters
73.34%
Peer Comparison
Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
---|---|---|---|---|---|
78.6(0.9%) | 84.1 | ||||
29.75(1.5%) | 0.0 | ||||
1026.65(-2.1%) | 10.1 | ||||
305.2(0.0%) | 39.3 |